Symptomatic vascular complications after vascular closure device use following diagnostic and interventional catheterisation

VASA ◽  
2004 ◽  
Vol 33 (2) ◽  
pp. 78-81 ◽  
Author(s):  
Thalhammer ◽  
Aschwanden ◽  
Jeanneret ◽  
Labs ◽  
Jäger
Keyword(s):  
Current Literature ◽  
Vascular Complications ◽  
University Hospital ◽  
Closure Device ◽  
Ultrasound Guided ◽  
Vascular Closure Device ◽  
Device Use ◽  
Arterial Stenoses ◽  
The University ◽  
Stenotic Lesions

Background: Haemostatic puncture closure devices for rapid and effective hemostasis after arterial catheterisation are a comfortable alternative to manual compression. Implanting a collagen plug against the vessel wall may become responsible for other kind of vascular injuries i.e. thrombotic or stenotic lesions and peripheral embolisation. The aim of this paper is to report our clinically relevant vascular complications after Angio-Seal® and to discuss the results in the light of the current literature. Patients and methods: We report the symptomatic vascular complications in 17 of 7376 patients undergoing diagnostic or therapeutic catheterisation between May 2000 and March 2003 at the University Hospital Basel. Results: Most patients presented with ischaemic symptoms, arterial stenoses or occlusions and thrombotic lesions (n = 14), whereas pseudoaneurysms were extremely rare (n = 3). Most patients with ischaemic lesions underwent vascular surgery and all patients with a pseudoaneurysm were successfully treated by ultrasound-guided compression. Conclusions: Severe vascular complications after Angio-Seal® are rare, consistent with the current literature. There may be a shift from pseudoaneurysms to ischaemic lesions.

A New Access Site Management Tool: The Angio-Seal™ Hemostatic Puncture Closure Device

1995 ◽  
Vol 2 (3) ◽  
pp. 289-296 ◽  
Author(s):  
Michel Henry ◽  
Max Amor ◽  
Mohamed Allaoui ◽  
Olivier Tricoche
Keyword(s):  
Arterial Wall ◽  
Bypass Graft ◽  
Vascular Complications ◽  
Common Femoral Artery ◽  
Management Tool ◽  
Closure Device ◽  
Manual Compression ◽  
Vascular Closure Device ◽  
Arterial Lumen ◽  
Manual Pressure

Purpose: Given the increasing number of percutaneously applied endovascular therapies, the incidence of access-related vascular complications can be expected to rise, particularly in association with those techniques requiring large sheaths or anticoagulation. The need exists for a safe, easy to use, and effective hemostatic technique to replace the labor-intensive method of manual compression. Methods: A bioabsorbable, sheath-delivered vascular closure device (Angio-Seal™) has been developed that deposits a small collagen plug within the arterial wall to mechanically seal the puncture defect. An anchor connected by suture to the plug is first deployed in the arterial lumen and pulled flush against the interior arterial wall to guard against intraluminal deposition of the collagen. Results: The Angio-Seal device was deployed successfully in 80 (96%) of 83 attempts involving common femoral arteries accessed for peripheral angioplasty (n = 30), coronary angiography (n = 30), and coronary angioplasty (n = 16). Three popliteal artery access sites and one femoropopliteal bypass graft were also treated. Hemostasis was immediate in 78 cases (98%); 2 sites required a 5-minute manual compression to effect a secure seal. Three devices failed to deploy, and manual pressure was used to close the puncture. Nondeployment did not cause any sequelae, and no complications were encountered with the technique. Conclusions: This novel vascular closure device is quick (< 1 minute application time) and simple to use, providing a positive seal of common femoral artery puncture sites for both peripheral and coronary interventions. It appears to be a reliable alternative to standard manual hemostasis.

scholarly journals VASCULAR CLOSURE DEVICE FAILURE AND VASCULAR COMPLICATIONS IN CONTEMPORARY PRACTICE

2011 ◽  
Vol 57 (14) ◽  
pp. E1673
Author(s):  
Venkatesan D. Vidi ◽  
Sripal Bangalore ◽  
Michael E. Matheny ◽  
Sharon-Lise T. Normand ◽  
Frederic S. Resnic
Keyword(s):  
Vascular Complications ◽  
Closure Device ◽  
Vascular Closure Device ◽  
Device Failure ◽  
Contemporary Practice

Evaluation of the MANTA Vascular Closure Device in Transfemoral TAVI

2021 ◽  
Author(s):  
Lukasz Kmiec ◽  
Matthaeus Zerdzitzki ◽  
Christof Schmid ◽  
Kurt Debl ◽  
Samuel Sossalla ◽  
...  
Keyword(s):  
Academic Research ◽  
Case Series ◽  
Vascular Complications ◽  
Female Gender ◽  
Closure Device ◽  
Complication Rates ◽  
Imaging Data ◽  
Patient Death ◽  
Vascular Closure Device ◽  
Puncture Site

Abstract Background The MANTA vascular closure device (VCD) is a novel collagen plug-based VCD for large bore arteriotomies. The current literature regarding complication rates of this device is quite variable and mostly limited to relatively small case series. Methods This study is retrospective analysis of the MANTA VCD-related main access site complications according to Valve Academic Research Consortium-2 (VARC-2) criteria during the hospital stay. Particular attention was paid to the detailed analysis of multislice computed tomography with regard to the anatomy of the access vessel and the puncture site itself. Results A total of 524 patients underwent transfemoral transcatheter aortic valve implantation (TF TAVI) including the use of the MANTA device (18F) for percutaneous vascular closure. A group of 22 patients was excluded from the study due to incomplete imaging data. During the study period, we observed 28 major (5.6%) and five minor (1.0%) MANTA device-related vascular complications. There was no patient death related to these adverse events. Female gender, vessel angulation at the puncture site, and at least moderate calcification of the dorsal vessel segment were identified as independent predictors for major complications. Conclusions The MANTA device is a feasible option for vascular closure of large bore arteriotomies in patients undergoing TF TAVI or other percutaneous transfemoral interventions. Furthermore, we have identified novel predictors for device failure/complications that should be taken into account for selection of the appropriate closure device. To our knowledge, this report is one of the largest case series analyzing the use of the MANTA VCD.

scholarly journals VASCULAR CLOSURE DEVICE USE IN HIGH BLEEDING RISK PATIENTS REDUCES PERI-PROCEDURAL COMPLICATIONS AND IMPROVES COSTS

2014 ◽  
Vol 63 (12) ◽  
pp. A1803
Author(s):  
Brandon Porten ◽  
Craig Strauss ◽  
Ross Garberich ◽  
Ivan Chavez ◽  
Jeffrey Chambers ◽  
...  
Keyword(s):  
Bleeding Risk ◽  
Closure Device ◽  
Vascular Closure Device ◽  
Risk Patients ◽  
Procedural Complications ◽  
Device Use ◽  
High Bleeding Risk

Management of Haemostasis with Combined Use of Vascular Closure Devices and Bivalirudin – A Review

2011 ◽  
Vol 6 (2) ◽  
pp. 177
Author(s):  
Emanuela de Cillis ◽  
Giuseppe Massimo Sangiorgi ◽  
Alessandro Santo Bortone ◽  
◽  
◽  
...  
Keyword(s):  
High Risk ◽  
Vascular Complications ◽  
Coronary Intervention ◽  
Closure Device ◽  
Vascular Closure Device ◽  
High Risk Patients ◽  
Vascular Closure Devices ◽  
Combined Use ◽  
Percutaneous Coronary ◽  
Risk Patients

Bleeding and vascular complications related to invasive cardiovascular procedures are associated with significant morbidity and mortality. The aim of this article is to evaluate the literature to determine haemostasis strategies in percutaneous coronary intervention when using bivalirudin with or without a vascular closure device. The literature data seem to underline that the combination of vascular closure devices and bivalirudin was associated with significantly lower bleeding rates. However, these strategies were less often used among high-risk patients. We recommend that prospective clinical studies are undertaken to determine the potential disadvantages of using vascular closure devices and bivalirudin in combination in high-risk patients.

Perclose Proglide™ for vascular closure

2020 ◽  
Author(s):  
Armando Del Prete ◽  
Domenico Giovanni Della Rocca ◽  
Simone Calcagno ◽  
Riccardo Di Pietro ◽  
Giuseppe Del Prete ◽  
...  
Keyword(s):  
Vascular Complications ◽  
Effective Alternative ◽  
Closure Device ◽  
Manual Compression ◽  
Vascular Closure Device ◽  
Patient Discomfort ◽  
The Past ◽  
Vascular Closure Devices

In the past 20 years, numerous percutaneous vascular closure devices have been tested and compared with manual compression and to surgical cut-down. The suture-mediated closure device Perclose ProGlide™ system (Abbott Vascular, CA, USA) emerged as a safe and effective alternative for many procedures requiring either small or large bore vascular accesses. In this review, we will discuss the characteristics of this vascular closure device and the main studies that proved its potential to reduce vascular complications, time to deambulation, time to discharge and patient discomfort.

Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: Results from the HORIZONS-AMI trial

2014 ◽  
Vol 85 (3) ◽  
pp. 371-379 ◽  
Author(s):  
Timothy A. Sanborn ◽  
Matthew I. Tomey ◽  
Roxana Mehran ◽  
Philippe Généreux ◽  
Bernhard Witzenbichler ◽  
...  
Keyword(s):  
Primary Angioplasty ◽  
Closure Device ◽  
Vascular Closure Device ◽  
Device Use
Sign in / Sign up

Export Citation Format

Share Document